Literature DB >> 28043808

Effects of VPAC1 activation in nucleus ambiguus neurons.

Florin Liviu Gherghina1, Andrei Adrian Tica1, Elena Deliu2, Mary E Abood3, G Cristina Brailoiu4, Eugen Brailoiu5.   

Abstract

The pituitary adenylyl cyclase-activating polypeptide (PACAP) and its G protein-coupled receptors, PAC1, VPAC1 and VPAC2 form a system involved in a variety of biological processes. Although some sympathetic stimulatory effects of this system have been reported, its central cardiovascular regulatory properties are poorly characterized. VPAC1 receptors are expressed in the nucleus ambiguus (nAmb), a key center controlling cardiac parasympathetic tone. In this study, we report that selective VPAC1 activation in rhodamine-labeled cardiac vagal preganglionic neurons of the rat nAmb produces inositol 1,4,5-trisphosphate receptor-mediated Ca2+ mobilization, membrane depolarization and activation of P/Q-type Ca2+ channels. In vivo, this pathway converges onto transient reduction in heart rate of conscious rats. Therefore we demonstrate a VPAC1-dependent mechanism in the central parasympathetic regulation of the heart rate, adding to the complexity of PACAP-mediated cardiovascular modulation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic cardiac tone; Bradycardia; Calcium signaling; PACAP

Mesh:

Substances:

Year:  2016        PMID: 28043808      PMCID: PMC5303116          DOI: 10.1016/j.brainres.2016.12.026

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  36 in total

1.  (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist.

Authors:  Terry W Moody; Robert T Jensen; Mati Fridkin; Illana Gozes
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

2.  Mu-opioid receptors are located postsynaptically and endomorphin-1 inhibits voltage-gated calcium currents in premotor cardiac parasympathetic neurons in the rat nucleus ambiguus.

Authors:  M Irnaten; S A Aicher; J Wang; P Venkatesan; C Evans; S Baxi; D Mendelowitz
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 3.  Parasympathetic Vagal Control of Cardiac Function.

Authors:  Jhansi Dyavanapalli; Olga Dergacheva; Xin Wang; David Mendelowitz
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

4.  Central cardiovascular effects induced by intracisternal PACAP in dogs.

Authors:  Y Seki; Y Suzuki; M K Baskaya; K Saito; M Takayasu; M Shibuya; K Sugita
Journal:  Am J Physiol       Date:  1995-07

5.  Pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in autonomic regulatory areas of the rat medulla oblongata.

Authors:  G Légrádi; S Shioda; A Arimura
Journal:  Neurosci Lett       Date:  1994-08-01       Impact factor: 3.046

6.  Inhibition of voltage-gated Ca(2+) current by PACAP in rat adrenal chromaffin cells.

Authors:  Mark S Jorgensen; Jihong Liu; Julye M Adams; William B Titlow; Brian A Jackson
Journal:  Regul Pept       Date:  2002-01-15

7.  Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Joseph E Rabinowitz; Douglas G Tilley; Khalid Benamar; Walter J Koch; Eugen Brailoiu
Journal:  J Neurochem       Date:  2013-07-19       Impact factor: 5.372

8.  Analysis of systemic and pulmonary vascular responses to PACAP and VIP: role of adrenal catecholamines.

Authors:  R K Minkes; T J McMahon; T R Higuera; W A Murphy; D H Coy; P J Kadowitz
Journal:  Am J Physiol       Date:  1992-12

9.  C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors.

Authors:  P Gourlet; A Vandermeers; M C Vandermeers-Piret; J Rathé; P De Neef; P Robberecht
Journal:  Regul Pept       Date:  1996-04-23

10.  Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats.

Authors:  T Murase; K Kondo; K Otake; Y Oiso
Journal:  Neuroendocrinology       Date:  1993-06       Impact factor: 4.914

View more
  2 in total

1.  Innate frequency-discrimination hyperacuity in Williams-Beuren syndrome mice.

Authors:  Christopher M Davenport; Brett J W Teubner; Seung Baek Han; Mary H Patton; Tae-Yeon Eom; Dusan Garic; Benjamin J Lansdell; Abbas Shirinifard; Ti-Cheng Chang; Jonathon Klein; Shondra M Pruett-Miller; Jay A Blundon; Stanislav S Zakharenko
Journal:  Cell       Date:  2022-09-23       Impact factor: 66.850

2.  Histopathology of acute colchicine intoxication: novel findings and their association with clinical manifestations.

Authors:  Shojiro Ichimata; Yukiko Hata; Kojiro Hirota; Naoki Nishida
Journal:  J Toxicol Pathol       Date:  2022-04-03       Impact factor: 1.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.